Fylde and Wyre Policies

Fylde and Wyre Policies
Click each header to expand its content

Commissioning Policies

NameSizeHits
Fwccg-Commissioning-Policies-Introductory-Document 89 KB40
Fwccg-Commissioning-Policy-No-10-Treatment-of-Varicose-Veins 0.1 MB68
Fwccg-Commissioning-Policy-No-12-Testing-for-Malignant-Hyperthermia 0.1 MB37
Fwccg-Commissioning-Policy-No-17-Services-that-are-the-subject-of-Guidance-from-the-National-Institute-of-Health-and-Clinical-Excellence 0.1 MB27
Fwccg-Commissioning-Policy-No-19-Specified-Services-for-which-provision-in-service-agreements-may-be-limited 0.2 MB32
Fwccg-Commissioning-Policy-No-2-Choice-of-Service-Provider-for-Health-Care-Ver2 0.2 MB23
Fwccg-Commissioning-Policy-No-20-Specified-Expensive-Services 0.1 MB27
Fwccg-Commissioning-Policy-No-21-Specified-Non-clinical-issues 0.1 MB28
Fwccg-Commissioning-Policy-No-24-Complex-Cases-through-the-Commissioning-Panel 0.2 MB26
Fwccg-Commissioning-Policy-No-26-Lumbar-spine-procedures 0.3 MB21
Fwccg-Commissioning-Policy-No-3-Monitoring-Enforcing-of-CCG-Policies-for-the-Comm-of-Appropriate-Effective-and-Priority-Health-Care 0.1 MB21
Fwccg-Commissioning-Policy-No-34-Spinal-Cord-Stimulation 38 KB31
Fwccg-Commissioning-Policy-No-4-Application-Amendment-Waiver-of-Policies-for-the-Comm-of-Appropriate-Effective-and-Priority-Health-Care 0.4 MB25
Fwccg-Commissioning-Policy-No-4-att-Process-map-appeals-v3 0.1 MB24
Fwccg-Commissioning-Policy-No-9-Reversal-of-Sterilisation 0.1 MB29
Fwccg-Complementary-and-Alternative-Therapies-new-Jan-2018 88 KB26
Fwccg-Policy For Commissioning Spinal Injection Radiofrequency Denervation For Low Back Pain V1 0.6 MB31
Fwccg-Policy Number 1 Statement Of Principles 0.3 MB24
Fwccg-Policy Number 2 General Policy IFR Decision Making 0.4 MB42
Fwccg-Policy Number 3 Considering Applications For Exceptionality 0.3 MB59
Fwccg-Policy-for-Assisted-Conception-Services 0.3 MB70
Fwccg-Policy-for-cosmetic-procedures-0318 64 KB69
Fwccg-Policy-for-Endoscopic-Procedures-on-the-Knee-Joint-Cavity-July-2017-v6 . 0.2 MB32
Fwccg-Policy-for-excision-of-the-uterus-v1 0.1 MB31
Fwccg-Policy-for-Grommets-v1 0.1 MB29
Fwccg-Policy-for-Hip-Arthroscopy-0318 42 KB33
Fwccg-Policy-for-hysteroscopy-0318 44 KB26
Fwccg-Policy-for-insulin-pump-provision-v1 0.1 MB19
Fwccg-Policy-for-Male-Circumcision-v4 0.2 MB39
Fwccg-Policy-for-photorefractive-surgery-v1 0.1 MB27
Fwccg-Policy-for-Surgical-Release-of-Trigger-Finger-Vs5-141216 0.2 MB42
Fwccg-Policy-for-Surgical-Treatment-of-Carpal-Tunnel-Syndrome-V5-050717 0.2 MB30
Fwccg-Policy-for-Tonsillectomy-Adeno-Tonsillectomy-V8-050717 0.2 MB43
Fwccg-Policyfor-Dilatation-and-Curettage-0318 45 KB22
Policy for Chalazia Removal 0.2 MB15
Policy for Dupuytren's contracture 0.3 MB15
Policy for ganglia excision 0.2 MB16
Policy for Glucose Monitoring Devices (March 19 amends) 0.3 MB53
Policy for Haemorrhoid surgery 0.2 MB16
Policy for snoring surgery 0.2 MB18
Policy subacromial decompression 0.2 MB16

Commissioning Policy summaries

Corporate Policies

Information Governance

Medicines Optimisation

NameSizeHits
Actipatch for pain management 0.6 MB64
Albiglutide for type-2 diabetes mellitus 0.3 MB42
Alprostadil Cream For ED 0.3 MB31
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB40
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB43
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB36
Brimonidine For Erythema Of Rosacea 0.1 MB31
Brivaracetam for epilepsy 0.3 MB34
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB43
Certolizumab For Psoriatic Arthritis 0.1 MB31
Co-Proxamol For pain management 0.3 MB65
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB40
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB41
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB42
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB20
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB62
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB28
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB26
Denosumab for GIO 0.2 MB13
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB47
Eflornithine-cream-for-facial-hirsutism 0.2 MB31
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB20
Eslicarbazepine For Focal Seizures 0.1 MB30
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB42
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB41
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB22
Gluten-Free-Food-Products 0.3 MB32
Guanfacine-for-ADHD 0.3 MB39
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB35
Insulin Degludec And Liraglutide 0.2 MB28
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB35
Insulin-Degludec-for-DM 0.3 MB38
Insulin-Detemir-for-DM 0.2 MB25
Insuline-Glargine-for-T1DM 0.3 MB23
Insuline-Glargine-for-T2DM 0.3 MB22
Invicorp-injection-for-erectile-dysfunction 0.3 MB39
Ivermectin-cream-for-rosacea 0.3 MB28
JIA Policy For Adults (Version 1.0) 0.2 MB23
Lamotrigine-for-trigeminal-neuralgia 0.3 MB39
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB45
Levonorgestrel 13.5mg IUD 0.3 MB24
Lidocaine Plasters For PHN 0.2 MB24
Lidocaine-plasters-for-unlicensed-indications 0.3 MB38
Liothyronine-for-refractory-hypothyroidism 0.2 MB48
Liraglutide-for-obesity 0.3 MB37
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB35
Lisdexamfetamine-for-ADHD-update 0.3 MB31
Lurasidone-for-Schizophrenia 0.3 MB41
Magnaspartate For Hypomagnesaemia 0.3 MB25
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB32
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB22
Midazolam-Epistatus-for-seizures 0.2 MB32
Opicapone-for-Parkinsons-disease-v2 0.5 MB40
Ospemifene for VVA 0.2 MB21
Oxycodone-Naloxone-for-Restless-legs 0.3 MB23
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB83
Patiromer-for-hyperkalaemia 0.3 MB32
Patiromer-for-hyperkalaemia 2 0.3 MB38
Phosphodiesterase Type-5 Inhibitors 0.2 MB32
Pitolisant-for-Narcolepsyv2 0.3 MB30
Policy On Brand Inhaler Prescribing 0.3 MB37
Probiotics And VSL 0.3 MB33
Relvar Ellipta for COPD and asthma in adults 63 KB29
Rituximab-for-AIHA 0.4 MB35
Rituximab-for-ITP 0.4 MB36
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB40
Safinamide-for-Parkinsons-disease 0.3 MB43
Second Line Anti-TNF For PsA 0.2 MB37
Second-generation-LA-antipsychotics 0.3 MB42
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB27
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB38
Semaglutide for type 2 DM 0.2 MB15
Silk Garments For Eczema And Dermatitis 0.2 MB33
Simbrinza for chronic open angle glaucoma 0.1 MB24
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB37
Spironolactone For Acne 0.1 MB24
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB26
Tadalafil daily 0.3 MB36
Tapentadol for neuropathic pain in non-palliative care 0.4 MB35
Tapentadol for non-specific pain 0.2 MB33
Testosterone For Female Sexual Dysfunction 0.1 MB16
Tiotropium For Asthma 0.2 MB24
Tocilizumab SC For RA 0.1 MB27
Trelegy inhaler for COPD 0.3 MB35
Trimbow inhaler for COPD 0.4 MB46
Trimbow-inhaler-for-COPD 0.4 MB4
Ulipristal acetate for uterine fibroids 0.5 MB35
Umeclidinium For COPD 0.2 MB30
Vedolizumab For Crohn's Disease 0.2 MB21
Vesomni For Benign Prostatic Hyperplasia 0.1 MB21
Vitamins (inc Renavit) For Dialysis 0.3 MB28
Waterproof Cast Cover Policy 0.1 MB29
Xonvea for nausea and vomiting in pregnancy 0.1 MB15

Last updated on 8 February 2019 at 13:53 by communications manager